Appendix 3Y Change of Director's Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Ramsay Health Care Limited
ABN | 57 001 288 768 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Karen Penrose |
Date of last notice | 3 June 2020 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct interest - see below |
Indirect interest - no change | |
Nature of indirect interest | N/A |
(including registered holder) | |
Note: Provide details of the circumstances giving rise to the relevant | |
interest. | |
Date of change | 3 September 2021 |
No. of securities held prior to change | Indirect interest |
- 957 ordinary shares held indirectly | |
through GKP Acquisitions Pty Ltd | |
as trustee for the Karen Lee Super | |
Fund | |
Class | Share Rights acquired by way of salary |
sacrifice under the Non-Executive Director | |
Share Rights Plan | |
Upon vesting and exercise, the Share | |
Rights entitle the holder to be allocated | |
ordinary shares on a 1: 1 basis | |
Number acquired | 580 Share Rights |
Number disposed | Nil |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
Value/Consideration | $68.9588 average price per Share Right |
Note: If consideration is non-cash, provide details and estimated | (calculated using the VWAP of company |
valuation | |
shares traded on the ASX over the 5 | |
trading day period commencing on the | |
trading day after the FY21 preliminary full | |
year results are released to the market, in | |
accordance with the terms of the Ramsay | |
Non-Executive Director Share Rights Plan) | |
No. of securities held after change | Direct interest |
- 580 Share Rights acquired by way | |
of salary sacrifice under the Non- | |
Executive Director Share Rights | |
Plan | |
Indirect interest | |
- 957 ordinary shares held indirectly | |
through GKP Acquisitions Pty Ltd | |
as trustee for the Karen Lee Super | |
Fund | |
Nature of change | Share Rights acquired by way of salary |
Example: on-market trade, off-market trade, exercise of options, issue | sacrifice under the Non-Executive Director |
of securities under dividend reinvestment plan, participation in buy- | Share Rights Plan, as approved by |
back | |
shareholders at the Annual General | |
Meeting held on 24 November 2020. |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A | ||
Nature of interest | N/A | ||
Name of registered holder | N/A | ||
(if issued securities) | |||
Date of change | N/A | ||
No. and class of securities to which | N/A | ||
interest related prior to change | |||
Note: Details are only required for a contract in | |||
relation to which the interest has changed | |||
Interest acquired | N/A | ||
Interest disposed | N/A | ||
Value/Consideration | N/A | ||
Note: If consideration is non-cash, provide details | |||
and an estimated valuation | |||
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 | 01/01/2011 |
Appendix 3Y
Change of Director's Interest Notice
Interest after change | N/A |
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above | No |
traded during a +closed period where prior written clearance | |
was required? | |
If so, was prior written clearance provided to allow the trade to | N/A |
proceed during this period? | |
If prior written clearance was provided, on what date was this | N/A |
provided? | |
- See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3
Attachments
- Original document
- Permalink
Disclaimer
Ramsay Health Care Limited published this content on 03 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 September 2021 06:51:02 UTC.